Cancer

Views & Analysis

Patient research is critical to brand success, particularly ...

We see it time and time again in the treatment of cancer – pharma companies focusing all their effort on oncologists.

News

FDA approves Pfizer/Merck KGaA combo in advanced colorectal ...

The FDA has approved a combination of Pfizer’s Braftovi and Merck KGaA’s Erbitux for a form of untreated metastatic colorectal cancer, the first targeted drug regimen for this form of the d

News

KEYTRUDA is a prescription medicine used to treat a kind of skin cancer called melanoma

Keytruda 100mg/4mL Vial and Carton
2015

FDA reviews Merck & Co's Keytruda in new 'tumour agnostic' u...

Merck & Co’s Keytruda cancer immunotherapy could be set for another indication, which could open up for use in all cancer patients whose tumours have a certain genetic biomarker.

News

Cancer Research UK cuts research funding as COVID-19 hits in...

Cancer Research UK has cut funding to its research activities, as the charity faces a cut to its income by up to a quarter in the next financial year because of the impact of the coronaviru

News

Servier to acquire Danish cancer biotech Symphogen

France’s Servier has signed a deal to buy the Danish biotech Symphogen, which specialises in antibody-based therapies for cancer.

Views & Analysis

AI and cancer care: Three ways artificial intelligence may transform cancer outcomes

AI and cancer care: 3 ways artificial intelligence may trans...

Artificial intelligence (AI) and machine learning (ML) are transforming the way cancers are detected and staged, offering new hope to the millions of people affected by the diseases every y

Patient research is critical to brand success, particularly ...

FDA approves Pfizer/Merck KGaA combo in advanced colorectal ...

FDA reviews Merck & Co's Keytruda in new 'tumour agnostic' u...

Cancer Research UK cuts research funding as COVID-19 hits in...

Servier to acquire Danish cancer biotech Symphogen

AI and cancer care: 3 ways artificial intelligence may trans...

Dexcom is first to join FDA/CMS health tech pilot

Discover a new era of healthcare panel engagement: Grounded ...

Cancer

Editor's Picks